US Stock MarketDetailed Quotes

RGBPP REGEN BIOPHARMA INC

Watchlist

0.138
+0.037+36.95%

15min DelayTrading Nov 13 12:58 ET

0Market Cap0.00P/E (TTM)

REGEN BIOPHARMA INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Jun 30, 2024

(Q2)Mar 31, 2024

(Q1)Dec 31, 2023

(FY)Sep 30, 2023

(Q4)Sep 30, 2023

(Q3)Jun 30, 2023

(Q2)Mar 31, 2023

(Q1)Dec 31, 2022

(FY)Sep 30, 2022

(Q4)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-98.36%-172.59K

-294.64%-209.32K

-1,451.39%-162.34K

71.34%-173.92K

72.56%-23.41K

43.42%-87.01K

40.22%-53.04K

96.25%-10.46K

46.33%-606.92K

92.01%-85.29K

Net income from continuing operations

-31.15%-130.12K

-122.77%-122.47K

-121.38%-349.76K

-52.67%1.16M

-316.56%-325.03K

-100.15%-99.22K

99.92%-54.98K

-38.16%1.64M

136.12%2.44M

94.36%-78.03K

Operating gains losses

----

--0

---1.15K

-99.65%1.83K

----

Other non cash items

477.30%4.34K

--4.34K

436,700.00%4.37K

114.22%249.72K

402.37%250.86K

-102.20%-1.15K

--0

-100.00%1

106.39%116.57K

344.62%49.94K

Change In working capital

-502.39%-49.13K

-4,807.59%-91.19K

98.91%-21.79K

38.53%-1.93M

185.99%50.76K

100.02%12.21K

-100.00%1.94K

35.08%-1.99M

-149.80%-3.14M

80.55%-59.03K

-Change in receivables

-221.48%-27.43K

-152.16%-27.43K

-110.03%-12.3K

817.15%254.27K

19.76%56.55K

181.92%22.58K

290.79%52.58K

544.76%122.58K

69.34%-35.46K

269.48%47.22K

-Change in prepaid assets

-163.26%-7.5K

-89.24%200

-57.83%5K

21.79%20.95K

-47.04%-4.62K

77.19%11.86K

-72.66%1.86K

72.93%11.86K

135.72%17.2K

93.47%-3.14K

-Change in payables and accrued expense

82.31%17.17K

-314.15%-32.32K

64.67%32.27K

26.39%59.46K

-50.09%15.35K

-46.37%9.42K

-70.92%15.09K

136.86%19.6K

-86.59%47.04K

-64.12%30.75K

-Change in other current liabilities

--261

----

29.23%-2.15M

--0

-100.05%-35.95K

28.64%-2.12M

-171.29%-3.04M

63.65%-102.21K

-Change in other working capital

0.00%-31.64K

-47.81%-46.77K

11.22%-111.43K

47.81%-16.51K

-1.11%-31.64K

-2.25%-31.64K

0.00%-31.64K

-106.79%-125.52K

1.09%-31.64K

Cash from discontinued investing activities

Operating cash flow

-98.36%-172.59K

-294.64%-209.32K

-1,451.52%-162.34K

71.34%-173.92K

72.56%-23.41K

29.65%-87.01K

55.36%-53.04K

96.25%-10.46K

46.33%-606.92K

92.01%-85.29K

Investing cash flow

Cash flow from continuing investing activities

-94.95%25K

Net investment purchase and sale

----

-94.95%25K

----

Cash from discontinued investing activities

Investing cash flow

----

-94.95%25K

----

Financing cash flow

Cash flow from continuing financing activities

156.32K

62.94%162.94K

165.8K

359.21%243.75K

28,707.62%143.75K

100K

-106.90%-94.04K

-99.96%499

Net issuance payments of debt

--21K

-125.00%-25K

---46.5K

359.21%243.75K

28,707.62%143.75K

--0

--100K

--0

-106.90%-94.04K

-99.96%499

Net common stock issuance

--135.33K

--187.94K

--212.3K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

--156.32K

62.94%162.94K

--165.8K

359.21%243.75K

28,707.62%143.75K

--0

--100K

--0

-106.90%-94.04K

-99.96%499

Net cash flow

Beginning cash position

-10.93%78.11K

205.58%124.5K

136.38%121.04K

-92.96%51.2K

-99.38%692

-62.63%87.7K

-88.47%40.74K

-92.96%51.2K

--727.16K

-41.02%110.99K

Current changes in cash

81.31%-16.27K

-198.77%-46.38K

133.07%3.46K

110.33%69.83K

301.28%120.35K

29.65%-87.01K

139.52%46.96K

97.20%-10.46K

-192.96%-675.96K

-111.09%-59.79K

End cash Position

8,837.72%61.85K

-10.93%78.11K

205.58%124.5K

136.38%121.04K

-99.38%692

-62.63%87.7K

-88.47%40.74K

-92.96%51.2K

Free cash flow

-98.36%-172.59K

-294.64%-209.32K

-1,451.52%-162.34K

71.34%-173.92K

72.56%-23.41K

29.65%-87.01K

55.36%-53.04K

96.25%-10.46K

46.33%-606.92K

92.01%-85.29K

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Jun 30, 2024	(Q2)Mar 31, 2024	(Q1)Dec 31, 2023	(FY)Sep 30, 2023	(Q4)Sep 30, 2023	(Q3)Jun 30, 2023	(Q2)Mar 31, 2023	(Q1)Dec 31, 2022	(FY)Sep 30, 2022	(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-98.36%-172.59K	-294.64%-209.32K	-1,451.39%-162.34K	71.34%-173.92K	72.56%-23.41K	43.42%-87.01K	40.22%-53.04K	96.25%-10.46K	46.33%-606.92K	92.01%-85.29K
Net income from continuing operations	-31.15%-130.12K	-122.77%-122.47K	-121.38%-349.76K	-52.67%1.16M	-316.56%-325.03K	-100.15%-99.22K	99.92%-54.98K	-38.16%1.64M	136.12%2.44M	94.36%-78.03K
Operating gains losses	----	----	----	----	----	----	--0	---1.15K	-99.65%1.83K	----
Other non cash items	477.30%4.34K	--4.34K	436,700.00%4.37K	114.22%249.72K	402.37%250.86K	-102.20%-1.15K	--0	-100.00%1	106.39%116.57K	344.62%49.94K
Change In working capital	-502.39%-49.13K	-4,807.59%-91.19K	98.91%-21.79K	38.53%-1.93M	185.99%50.76K	100.02%12.21K	-100.00%1.94K	35.08%-1.99M	-149.80%-3.14M	80.55%-59.03K
-Change in receivables	-221.48%-27.43K	-152.16%-27.43K	-110.03%-12.3K	817.15%254.27K	19.76%56.55K	181.92%22.58K	290.79%52.58K	544.76%122.58K	69.34%-35.46K	269.48%47.22K
-Change in prepaid assets	-163.26%-7.5K	-89.24%200	-57.83%5K	21.79%20.95K	-47.04%-4.62K	77.19%11.86K	-72.66%1.86K	72.93%11.86K	135.72%17.2K	93.47%-3.14K
-Change in payables and accrued expense	82.31%17.17K	-314.15%-32.32K	64.67%32.27K	26.39%59.46K	-50.09%15.35K	-46.37%9.42K	-70.92%15.09K	136.86%19.6K	-86.59%47.04K	-64.12%30.75K
-Change in other current liabilities	--261	----	----	29.23%-2.15M	--0	--0	-100.05%-35.95K	28.64%-2.12M	-171.29%-3.04M	63.65%-102.21K
-Change in other working capital	0.00%-31.64K	0.00%-31.64K	-47.81%-46.77K	11.22%-111.43K	47.81%-16.51K	-1.11%-31.64K	-2.25%-31.64K	0.00%-31.64K	-106.79%-125.52K	1.09%-31.64K
Cash from discontinued investing activities
Operating cash flow	-98.36%-172.59K	-294.64%-209.32K	-1,451.52%-162.34K	71.34%-173.92K	72.56%-23.41K	29.65%-87.01K	55.36%-53.04K	96.25%-10.46K	46.33%-606.92K	92.01%-85.29K
Investing cash flow
Cash flow from continuing investing activities									-94.95%25K
Net investment purchase and sale	----	----	----	----	----	----	----	----	-94.95%25K	----
Cash from discontinued investing activities
Investing cash flow	----	----	----	----	----	----	----	----	-94.95%25K	----
Financing cash flow
Cash flow from continuing financing activities	156.32K	62.94%162.94K	165.8K	359.21%243.75K	28,707.62%143.75K	0	100K	0	-106.90%-94.04K	-99.96%499
Net issuance payments of debt	--21K	-125.00%-25K	---46.5K	359.21%243.75K	28,707.62%143.75K	--0	--100K	--0	-106.90%-94.04K	-99.96%499
Net common stock issuance	--135.33K	--187.94K	--212.3K	----	----	----	----	--0	----	----
Cash from discontinued financing activities
Financing cash flow	--156.32K	62.94%162.94K	--165.8K	359.21%243.75K	28,707.62%143.75K	--0	--100K	--0	-106.90%-94.04K	-99.96%499
Net cash flow
Beginning cash position	-10.93%78.11K	205.58%124.5K	136.38%121.04K	-92.96%51.2K	-99.38%692	-62.63%87.7K	-88.47%40.74K	-92.96%51.2K	--727.16K	-41.02%110.99K
Current changes in cash	81.31%-16.27K	-198.77%-46.38K	133.07%3.46K	110.33%69.83K	301.28%120.35K	29.65%-87.01K	139.52%46.96K	97.20%-10.46K	-192.96%-675.96K	-111.09%-59.79K
End cash Position	8,837.72%61.85K	-10.93%78.11K	205.58%124.5K	136.38%121.04K	136.38%121.04K	-99.38%692	-62.63%87.7K	-88.47%40.74K	-92.96%51.2K	-92.96%51.2K
Free cash flow	-98.36%-172.59K	-294.64%-209.32K	-1,451.52%-162.34K	71.34%-173.92K	72.56%-23.41K	29.65%-87.01K	55.36%-53.04K	96.25%-10.46K	46.33%-606.92K	92.01%-85.29K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data